Pharmacodynamics and pharmacokinetics of extended‐release metformin in patients with type 2 diabetes and chronic kidney disease stage 3B-Reference-Cited by-同舟云学术

Pharmacodynamics and pharmacokinetics of extended‐release metformin in patients with type 2 diabetes and chronic kidney disease stage 3B

Published:2021-10-04 Issue:1 Volume:24 Page:166-170
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Lalau Jean‐Daniel¹²^ORCID,Bennis Youssef³⁴,Al‐Salameh Abdallah¹²,Hurtel‐Lemaire Anne‐Sophie³,Fendri Salha²

Affiliation:

1. Department of Endocrinology‐Diabetes Mellitus‐Nutrition Amiens University Medical Center Amiens France

2. PériTox, UMR_I 01 University of Picardie Jules Verne Amiens France

3. Department of Clinical Pharmacology Amiens University Medical Center Amiens France

4. MP3CV Laboratory, UR UPJV 7517 University of Picardie Jules Verne Amiens France

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14554

Reference16 articles.

1. Overview of metformin: special focus on metformin extended release

2. The primary glucose‐lowering effect of metformin resides in the gut, not the circulation: results from short‐term pharmacokinetic and 12‐week dose‐ranging studies;Buse JB;Diabetes Care.,2016

3. Efficacy and side effect profile of different formulations of metformin: a systematic review and meta‐analysis;Tarry‐Adkins JL;Diabetes Ther Res Treat Educ Diabetes Relat Disord,2021

4. Steady-State Pharmacokinetics of a Novel Extended-Release Metformin Formulation

5. A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of Population Pharmacokinetic of Metformin;BioMed Research International;2022-12-19